Link Pharma Chem
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
March 6 (Reuters) - Link Pharmachem Ltd LIPC.BO:
LINK PHARMACHEM LTD - PURCHASED PLOT IN VADODARA FROM CHLORO CHEM OF INDIA
Source text for Eikon: ID:nBSE5s5vXD
Further company coverage: LIPC.BO
(([email protected];))
March 6 (Reuters) - Link Pharmachem Ltd LIPC.BO:
LINK PHARMACHEM LTD - PURCHASED PLOT IN VADODARA FROM CHLORO CHEM OF INDIA
Source text for Eikon: ID:nBSE5s5vXD
Further company coverage: LIPC.BO
(([email protected];))
Nov 8 (Reuters) - Link Pharma Chem Limited LIPC.BO:
NAMES SANJIB DUTTA AS CFO
Source text for Eikon: ID:nBSE8nGlSK
Further company coverage: LIPC.BO
(([email protected];;))
Nov 8 (Reuters) - Link Pharma Chem Limited LIPC.BO:
NAMES SANJIB DUTTA AS CFO
Source text for Eikon: ID:nBSE8nGlSK
Further company coverage: LIPC.BO
(([email protected];;))
Oct 31 (Reuters) - Link Pharma Chem Limited LIPC.BO:
JAYESH PUSHPAVADAN JANI RESIGNS AS CHIEF FINANCIAL OFFICER
Source text for Eikon: ID:nBSE543VF3
Further company coverage: LIPC.BO
(([email protected];))
Oct 31 (Reuters) - Link Pharma Chem Limited LIPC.BO:
JAYESH PUSHPAVADAN JANI RESIGNS AS CHIEF FINANCIAL OFFICER
Source text for Eikon: ID:nBSE543VF3
Further company coverage: LIPC.BO
(([email protected];))
Sept 22 (Reuters) - Link Pharma Chem Limited LIPC.BO:
LINK PHARMA CHEM REAPPOINTS SATISH G. THAKUR AS CHAIRMAN
Source text for Eikon: ID:nBSE7nhNxD
Further company coverage: LIPC.BO
(([email protected];))
Sept 22 (Reuters) - Link Pharma Chem Limited LIPC.BO:
LINK PHARMA CHEM REAPPOINTS SATISH G. THAKUR AS CHAIRMAN
Source text for Eikon: ID:nBSE7nhNxD
Further company coverage: LIPC.BO
(([email protected];))
Link Pharma Chem Limited LIPC.BO:
LINK PHARMA CHEM LIMITED- NANDESARI PLANT RESTARTED
LINK PHARMA CHEM LIMITED- ORDER RECEIVED FROM GUJARAT POLLUTION CONTROL BOARD
Source text for Eikon: ID:nBSE59bwYz
Further company coverage: LIPC.BO
Link Pharma Chem Limited LIPC.BO:
LINK PHARMA CHEM LIMITED- NANDESARI PLANT RESTARTED
LINK PHARMA CHEM LIMITED- ORDER RECEIVED FROM GUJARAT POLLUTION CONTROL BOARD
Source text for Eikon: ID:nBSE59bwYz
Further company coverage: LIPC.BO
May 29 (Reuters) - Link Pharma Chem Limited LIPC.BO:
LINK PHARMA CHEM LIMITED - RE-APPOINTS RISHIKESH THAKUR AS MANAGING DIRECTOR
LINK PHARMA CHEM LIMITED - RE-APPOINTS SATISH G. THAKUR AS CHAIRMAN
Source text for Eikon: ID:nBSEHzg9Q
Further company coverage: LIPC.BO
(([email protected];;))
May 29 (Reuters) - Link Pharma Chem Limited LIPC.BO:
LINK PHARMA CHEM LIMITED - RE-APPOINTS RISHIKESH THAKUR AS MANAGING DIRECTOR
LINK PHARMA CHEM LIMITED - RE-APPOINTS SATISH G. THAKUR AS CHAIRMAN
Source text for Eikon: ID:nBSEHzg9Q
Further company coverage: LIPC.BO
(([email protected];;))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Link Pharma Chem do?
Link Pharma Chem Ltd specializes in the production of thionyl chloride and various inorganic chemical intermediates.
Who are the competitors of Link Pharma Chem?
Link Pharma Chem major competitors are Emmessar Biotech&Nut, StarsourceMultitrade, Unjha Formulations, Beryl Drugs, Ortin Global, Kobo Biotech, Omkar Pharmachem. Market Cap of Link Pharma Chem is ₹12 Crs. While the median market cap of its peers are ₹12 Crs.
Is Link Pharma Chem financially stable compared to its competitors?
Link Pharma Chem seems to be less financially stable compared to its competitors. Altman Z score of Link Pharma Chem is 2.23 and is ranked 6 out of its 8 competitors.
Does Link Pharma Chem pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Link Pharma Chem latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Link Pharma Chem allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments
How strong is Link Pharma Chem balance sheet?
Balance sheet of Link Pharma Chem is moderately strong, But short term working capital might become an issue for this company.
Is the profitablity of Link Pharma Chem improving?
Yes, profit is increasing. The profit of Link Pharma Chem is ₹0.08 Crs for Mar 2026, -₹1.03 Crs for Mar 2025 and -₹1.36 Crs for Mar 2024
Is the debt of Link Pharma Chem increasing or decreasing?
Yes, The net debt of Link Pharma Chem is increasing. Latest net debt of Link Pharma Chem is ₹6.08 Crs as of Mar-26. This is greater than Mar-25 when it was ₹5.72 Crs.
Is Link Pharma Chem stock expensive?
Link Pharma Chem is not expensive. Latest PE of Link Pharma Chem is 0, while 3 year average PE is 29.66. Also latest EV/EBITDA of Link Pharma Chem is 14.9 while 3yr average is 23.29.
Has the share price of Link Pharma Chem grown faster than its competition?
Link Pharma Chem has given better returns compared to its competitors. Link Pharma Chem has grown at ~9.77% over the last 10yrs while peers have grown at a median rate of 2.29%
Is the promoter bullish about Link Pharma Chem?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Link Pharma Chem is 52.4% and last quarter promoter holding is 52.4%.
Are mutual funds buying/selling Link Pharma Chem?
The mutual fund holding of Link Pharma Chem is stable. The current mutual fund holding in Link Pharma Chem is 0.02% while previous quarter holding is 0.02%.